Month: February 2023
NGS MAC Allows Non-Physician Practitioners with Autonomy to Prescribe TMS
MALVERN, Pa., Feb. 10, 2023 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced a healthcare policy update from National Government Services, Inc. (NGS) that increases access for patients to its NeuroStar® Advanced Therapy for Mental Health transcranial magnetic stimulation (TMS). The NGS policy, effective April 1, 2023, will allow non-physician practitioners (NPPs) who are within their scope of practice to order and provide TMS treatment to their patients with major depressive disorder (MDD).
“We recognize and appreciate the significant role psychiatric...
Staffing 360 Solutions Announces Closing of $5 Million Public Offering
Written by Customer Service on . Posted in Public Companies.
NEW YORK, Feb. 10, 2023 (GLOBE NEWSWIRE) — Staffing 360 Solutions, Inc. (NASDAQ: STAF) (“Staffing 360” or “the Company”), a staffing company executing an international buy-integrate-build strategy through the acquisition of staffing organizations in the United States and the United Kingdom, today announced the closing of its previously announced public offering of 1,884,516 units (or pre-funded units in lieu thereof), each unit consisting of one share of common stock (or pre-funded warrant in lieu thereof) and one warrant to purchase one share of common stock, at an offering price to the public of $2.6532 per unit (or pre-funded unit in lieu thereof). The warrants have an exercise price of $2.47 per share, are immediately exercisable, and will expire five years from issuance.
H.C. Wainwright & Co. acted as the exclusive placement...
Nine Mile Metals Announces Engagement of Oak Hill Financial Inc. for Investor Relations
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, Feb. 10, 2023 (GLOBE NEWSWIRE) — NINE MILE METALS LTD. (CSE: NINE, OTCQB: VMSXF, FSE: KQ9) (the “Company” or “Nine Mile”), is pleased to announce it has entered into an advisory services agreement (the “Consulting Agreement”) with Oak Hill Financial Inc. (“Oak Hill”) to provide business and capital markets advisory services including investor relations.
Nine Mile has entered into the Consulting Agreement dated February 8, 2023, at a monthly fee of $10,000 plus applicable taxes, for as long as the agreement is in effect. Oak Hill will provide investor relations services to Nine Mile with a focus on providing turn-key solutions for investor relations, marketing in the investment community, targeting advisor channels of distribution.
Patrick J Cruickshank, MBA, CEO and Director, stated, “We are extremely...
Kadant to Hold Earnings Conference Call on Thursday, February 16, 2023
Written by Customer Service on . Posted in Public Companies.
WESTFORD, Mass., Feb. 10, 2023 (GLOBE NEWSWIRE) — Kadant Inc. (NYSE: KAI) announced it will release its 2022 fourth quarter and full-year results after the market closes on Wednesday, February 15, 2023 and will hold a webcast the next day, Thursday, February 16, 2023 at 11:00 a.m. eastern time. During the call the Company will discuss its fourth quarter and full-year financial performance and future expectations.
To listen to the live call and view the webcast, go to the “Investors” section of the Company’s website at www.kadant.com. Participants interested in joining the call’s live question and answer session are required to register by clicking here or the Q&A link on our website to receive a dial-in number and unique PIN. It is recommended that you join the call 10 minutes prior to the start of the event. A replay of the...
POET Technologies Announces Acceleration of Warrants
Written by Customer Service on . Posted in Public Companies.
TORONTO, Feb. 10, 2023 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Corporation”) (TSXV: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer™, Photonic Integrated Circuits (PICs) and light sources for the data center, tele-communication and artificial intelligence markets, announces today that the expiry date of all common share purchase warrants of the Corporation (the “Warrants”) that were issued on February 11, 2021, is being accelerated to 30 days (the “Warrant Acceleration”) in accordance with the terms of the warrant indenture governing the Warrants dated February 11, 2021, as amended and supplemented (the “Warrant Indenture”).
Pursuant to the terms of the Warrant Indenture and as required by the policies of the TSX Venture...
Smart Sand, Inc. Announces Timing of Fourth Quarter and Full Year 2022 Earnings Release and Investor Conference Call
Written by Customer Service on . Posted in Public Companies.
SPRING, Texas, Feb. 10, 2023 (GLOBE NEWSWIRE) — Smart Sand, Inc. (NASDAQ: SND) (the “Company”) announced today that it will release its fourth quarter and full year financial results after the market closes on Tuesday, February 28, 2023. The Company will hold a conference call for investors on Wednesday, March 1, 2023, at 10:00 a.m. Eastern Time to discuss recent events and the results. Chuck Young, the Company’s chief executive officer, Lee Beckelman, the Company’s chief financial officer and John Young, the Company’s chief operating officer, will host the call.
Investors are invited to listen to a live webcast of the conference call by visiting the “Investors” section, then selecting “More Events” under the “Upcoming Events” section of the Company’s website at www.smartsand.com. The call can be accessed via teleconference at:...
Rezolute Reports Second Quarter Fiscal 2023 Results and Highlights Company Progress
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Initiated Phase 2 proof-of-concept study of RZ402
Anticipate initiation of global Phase 3 clinical study for RZ358 in mid 2023
REDWOOD CITY, Calif., Feb. 10, 2023 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company dedicated to developing transformative therapies with the potential to transform the treatment paradigms of devastating metabolic diseases, today announced its financial results for the second quarter of fiscal 2023 ended December 31, 2022.
“The past quarter was marked by steady execution across our pipeline as we continue to advance toward our goal of bringing transformative therapies to patients across the spectrum of metabolic diseases,” said Nevan Charles Elam, Chief Executive Officer and Founder of Rezolute. “In December, we initiated a Phase 2 proof-of-concept study for...
DIAGNOS Announces Grant of Stock Options
Written by Customer Service on . Posted in Public Companies.
BROSSARD, Quebec, Feb. 10, 2023 (GLOBE NEWSWIRE) — February 10, 2023 – Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces the grant of an aggregate number of 1,275,000 stock options to its officers, employees, consultants and directors.
Stock options vest at 50% per year, commencing with the first anniversary of the grant. The exercise price of these stock options has been established at $0.425 per share. The expiry date to which these stock options can be exercised has been fixed to February 10, 2028.
The stock options remain subject to the approval of the TSX Venture Exchange.
All monies quoted in this press release shall be stated and paid in lawful money...
Enovis to Host Fourth Quarter and Full Year 2022 Conference Call on February 23rd
Written by Customer Service on . Posted in Public Companies.
Wilmington, DE, Feb. 10, 2023 (GLOBE NEWSWIRE) — Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its fourth quarter and full year 2022 financial results on Thursday, February 23, 2023 at 8:30AM ET and issue an earnings press release earlier that morning. A presentation related to the call will be available on www.enovis.com in the “Investors” section.
Conference call/Webcast Information
Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (833) 630-1956 (U.S. callers) and (412) 317-1837 (International callers) and ask to join the Enovis call. A link to a replay of the call will also be available on the Enovis website later...
Allied Copper Increases Non-Brokered Financing From $2,000,000 To $4,000,000
Written by Customer Service on . Posted in Public Companies.
Vancouver, British Columbia, Feb. 10, 2023 (GLOBE NEWSWIRE) — Allied Copper Corp. (TSX-V: CPR, OTCQB: CPRRF) (the “Company” or “Allied Copper”) is pleased to announce that, further to its press release of January 30, 2023, it has increased its non-brokered private placement from 10,000,000 units of the Company (each, a “Unit”) at a price of $0.20 per Unit for aggregate gross proceeds to the Company of up to $2,000,000 to 20,000,000 Units of the Company for aggregate gross proceeds of up to $4,000,000 (the “Offering”).
Each Unit shall be comprised of one common share in the capital of the Company (each, a “Share”) and one half of one common share purchase warrant (each whole warrant, a “Warrant”), with each Warrant entitling the holder thereof to purchase one additional common share at an exercise price of $0.30 for a period of...